- email:registrations@informa-ls.com
- phone:+44(0)20 7017 7481
 |
G Protein-Coupled Receptors in Drug Discovery
20 - 21 March 2012
|
10th Annual G Protein-Coupled Receptors in Drug Discovery 2012
Meet world renowned GPCR experts and examine the latest scientific and technical breakthroughs at Europe's leading GPCRs congress
The latest and most exciting developments in biased agonism, in silico modelling, allosterism, signalling & trafficking, GPCR structure & mechanism, lead optimisation, preclinical and clinical translation, understanding modes of action and receptor binding kinetics, receptor heterodimerisation, screening methodologies and medicinal chemistry for GPCRs will be presented.
Why is G Protein-Coupled Receptors in Drug Discovery a MUST ATTEND for 2012?
Reviewing the past 12 months and looking to the future in GPCR research
GPCR 2012 Conference Speakers: Over 30 Leading International GPCR Experts from Industry and Academia
GPCR 2012 Conference Speakers: Over 30 Leading International GPCR Experts from Industry and Academia
Graeme Milligan
Professor of Molecular Pharmacology
University of Glasgow, UK
|
Roger K. Sunahara,
Associate Professor of Pharmacology,
University of Michigan Medical School, USA
|
Ad P. IJzerman,
Leiden/Amsterdam Center for Drug Research, Leiden University,
The Netherlands
|
75% NEW Speakers for GPCRs 2012 discussing the next wave of commercially viable GPCR research including:
• Mark Dowling, Research Investigator III, Receptor Biology, Novartis Pharmaceuticals UK Limited, UK
• Stephen Hunt III, Chief Scientific Officer, Anchor Therapeutics, Inc. USA
• Sonia Poli, Head of CNS and Non-Clinical Development, Addex Pharma SA, Switzerland
• Christopher J. Langmead, Head of Pharmacology, Heptares Therapeutics Ltd, UK
• Thomas P. Sakmar, Laboratory of Molecular Biology & Biochemistry, The Rockefeller University, USA
• So Iwata, David Blow Chair of Biophysics, Imperial College London, UK
• Jerome Bernard, Director, EuroscreenFAST Business Unit, Euroscreen S.A. Belgium
• Gayathri Swaminath, Senior Scientist, Amgen, Inc. USA
• Andrew B. Tobin, Department of Cell Physiology and Pharmacology, University of Leicester, UK
• Teresa Bennett, VP Research, Vivia Biotech, Spain
• Christopher A Reynolds, Department of Biological Sciences, University of Essex, UK
• Mark Wheatley, Chair of Biochemical Pharmacology, University of Birmingham, UK
Targets and Tools 2012: Sponsors
Targets and Tools: Exhibitors
Promotional Participant
G Protein Coupled Receptors 2012: Media Partners
GPCRs is part of Drug Discovery Targets & Tools 2012
GPCR Symposiums and Seminars
Pre-Conference Symposium | Monday 19 March 2012
New Directions for GPCR Small Molecule Drug Discovery
Chaired by
Ad P. IJzerman, Leiden/Amsterdam Center for Drug Research, Leiden University, The Netherlands
Evening Seminar, Discussion and Dinners | Tuesday 20 March 2012
1. Targeting GPCRs with Antibodies
Sergej Kiprijanov, Vice President of Research and Preclinical Development, Affitech Research AS, Norway
Christoph Ullmer, Senior Principle Scientist, F. Hoffmann-La Roche, Ltd., Switzerland
Post-Conference Symposium | Thursday 22 March 2012
Application of Novel Screening Methodologies for GPCRs
Chaired by
Rochdi Bouhelal, Senior Scientist I, Center for Proteomic Chemistry, Novartis Institutes for Biomedical Research, Switzerland
Informa's Targets and Tools Attendees in 2011 include:
Feeds | Like | Share    |
Dates and Venues
20 Mar 2012 - 21 Mar 2012
Andel's Hotel Berlin
G Protein-Coupled Receptors in Drug Discovery 2011 Reviews
"Exciting congress with many updated presentations"
"Informative and up-to-date overview of broad developments in the field"
Latest tweets
Join our linked in group - Drug Discovery Targets and Tools - Here and start networking with the conference attendees before the event!